Comprehensive preclinical pharmacology and pharmacodynamics evaluation bench & full range of animal models
KCI Biotech is a preclinical neurology CRO dedicated to neurological drug discovery. Integrating deep neuroscience pharmacology expertise, our preclinical CRO CNS platforms provide reliable, GLP-compliant in vivo evaluations to accelerate translational success.
Because complex cognitive, motor, and blood-brain barrier pathways cannot be replicated in vitro, reliable CNS disease models are indispensable. Partnering with a dedicated preclinical neuroscience CRO provides the objective data, behavioral readouts, and controlled conditions required to bridge early research to clinical trials.
KCI Biotech offers reproducible in vivo models for neurodegenerative, neurodevelopmental, and psychiatric indications:
KCI Biotech delivers integrated preclinical solutions to de-risk neurological drug candidates:
Portfolio: The CNS CRO platform features a variety of specific CNS models within a library of 500+ validated disease models.
Facilities & Species: 18,000 m² AAALAC-accredited facilities supporting mice, rats, rabbits, dogs, and non-human primates.
Evaluation Platforms: Behavioral tracking (Morris Water Maze, Y Maze), 1.5T MRI/CT imaging, and neuropathology.
Track Record: Proven experience supporting 200+ IND filings (NMPA/FDA) for 1000+ global clients.
From stereotactic microinjection to PK/PD profiling, we provide end-to-end support for your preclinical pipeline. Contact our team today.

Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china